NeuroImmunePharma, founded by Daniel Luo, Dr. Anumantha Kanthasamy & Dr. Vellareddy Anantharam, aims to translate the new basic Parkinson research findings into novel therapeutic strategies that could slow down or cure Parkinson’s disease by altering immune and trophic support within the brain.